Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Eiken Chemical Co., Ltd. ( (JP:4549) ).
Eiken Chemical Co., Ltd. announced the retraction of a shareholder proposal by Dalton Kizuna Fund, a major shareholder. After evaluating six proposed director candidates, the company decided to nominate two candidates, Mr. Kinose and Mr. Toda, for its board. This decision aims to maintain board independence while enhancing corporate value, as both candidates have committed to acting independently of Dalton’s interests.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. operates within the chemical industry, focusing on the development and production of diagnostic reagents and equipment. The company is known for its contributions to medical diagnostics and aims to enhance corporate value through strategic governance.
Average Trading Volume: 103,312
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen70.16B
For an in-depth examination of 4549 stock, go to TipRanks’ Stock Analysis page.